Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Censoring Survival Data01:09

Censoring Survival Data

73
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
73
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

166
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
166
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

115
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
115
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

114
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
114
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

201
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
201
Actuarial Approach01:20

Actuarial Approach

69
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
69

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Hypoglycemia Occurrence and Risk Factors in Insulin Independent Patients After Total Pancreatectomy With Islet Autotransplantation.

Clinical transplantation·2026
Same author

Association Between Sensorineural Hearing Loss and Neurocognitive Performance in Survivors of Childhood Cancer: A Systematic Review and Meta-Analysis.

Cancer medicine·2025
Same author

Association of Left Atrial Function With Mitral Regurgitation: The Atherosclerosis Risk in Communities Study.

Journal of the American Heart Association·2025
Same author

Associations of Midlife Leukocyte Telomere Length With Measures of Left Atrial Function in Community-Dwelling Older Adults: The ARIC Study.

Journal of the American Heart Association·2025
Same author

Dose selection criteria to identify the optimal dose based on ranked efficacy-toxicity outcomes without reliance on clinical utilities.

Statistical methods in medical research·2025
Same author

Markers of Left Atrial Myopathy: Prognostic Usefulness for Ischemic Stroke and Dementia in People in Sinus Rhythm.

Stroke·2025

相关实验视频

Updated: Jun 17, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

对分组审查的复合终点的统计方法.

Anne Eaton1

  • 1Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.

Clinical trials (London, England)
|August 8, 2024
PubMed
概括

本研究引入了新的统计方法,以准确分析复合终点的临床试验数据,特别是针对组件智能的审查,以改善无事件生存估计.

科学领域:

  • 生物统计学 生物统计学
  • 临床试验方法论 临床试验方法论
  • 生存分析的分析.

背景情况:

  • 在临床试验中经常使用复合终点,结合多个事件.
  • 分部智能审查,不同事件被不同方式审查,提出了分析挑战.
  • 当前的方法可能会在分析混合审查类型的复合终点时引入偏差.

研究的目的:

  • 在复合终点中开发和介绍处理组件智能审查的统计方法.
  • 在混合审查的情况下准确估计无事件生存曲线.
  • 通过使用危险比率来评估治疗对无事件生存的影响.

主要方法:

  • 专注于复合终点,包括死亡 (右边被审查) 和非致命事件 (间隔被审查).
  • 开发专门设计用于组件智能审查的统计方法.
  • 应用这些方法来分析婴儿养实践随机试验的数据.

主要成果:

  • 拟议的方法提供了无事件生存率的公正估计.
  • 在组件智能审查下,对治疗效应的准确危险比估计.
  • 在现实世界的临床研究中证明方法的实用性.

结论:

关键词:
复合终点是复合的终点.审查 审查 审查没有进展的生存率.时间到事件的时间.

更多相关视频

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

相关实验视频

Last Updated: Jun 17, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
  • 开发的统计方法有效地解决了复合终点中的组件智能审查.
  • 这些方法为复杂的临床试验数据提供了更可靠的生存分析.
  • 准确的分析对于理解混合审查模式的研究中的治疗疗效至关重要.